Molecular characterization of inflammation and Staphylococcus aureus colonization of involved skin of atopic dermatitis patients: A non-invasive approach

Skin Pharmacology and Physiology

Volumn 21, Issue 5, 2008, Pages 260-268

  Casas, C ^a   Ginisty, H ^b   Alvarez Georges, S ^a   Viode C ^a   Lejeune, O ^a   Rouvrais, C ^a   Schmitt, A M ^a   Redoules D ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b GTP Technology   (France)

Author keywords

Atopic dermatitis; Cytokine markers; Enterotoxins; Protein A; Real time polymerase chain reaction; Staphylococcus aureus

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; TOXIN;

ADULT; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; ENVIRONMENTAL FACTOR; FEMALE; GENE SEQUENCE; GENETIC CODE; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING ATOPIC DERMATITIS INDEX; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS;

BACTERIAL TOXINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DNA, BACTERIAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFLAMMATION; INTERLEUKINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 51649096602     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000143391     Document Type: Article

References (37)

1. Novak N, Bieber T, Leung DY: Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003;112:S128-S139.
2. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-446.
3. Sandilands A, Terron-Kwiatkowski A, Hull PR, O'Regan GM, Clayton TH, Watson RM, Carrick T, Evans AT, Liao H, Zhao Y, Campbell LE, Schmuth M, Gruber R, Janecke AR, Elias PM, van Steensel MA, Nagtzaam I, van Geel M, Steijlen PM, Munro CS, Bradley DG, Palmer CN, Smith FJ, McLean WH, Irvine AD: Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007;39:650-654.
4. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, Duff GW, Ward SJ, Tazi-Ahnini R: New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006;118:3-21.
5. Bachert C, Zhang N, van Zele T, Gevaert P, Patou J, van Cauwenberge P: Staphylococcus aureus enterotoxins as immune stimulants in chronic rhinosinusitis. Clin Allergy Immunol 2007;20:163-175.
6. Zollner TM, Wichelhaus TA, Hartung A, Von Mallinckrodt C, Wagner TO, Brade V, Kaufmann R: Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000;30:994-1000.
7. Leung DY, Bieber T: Atopic dermatitis. Lancet 2003;361:151-160.
8. Lin YT, Shau WY, Wang LF, Yang YH, Hwang YW, Tsai MJ, Tsao PN, Chiang BL: Comparison of serum specific IgE antibodies to staphylococcal enterotoxins between atopic children with and without atopic dermatitis. Allergy 2000;55:641-646.
9. Ong PY, Leung DY: Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep 2006;6:384-389.
10. Nakano H, Tsutsui H, Terada M, Yasuda K, Matsui K, Yumikura-Futatsugi S, Yamanaka K, Mizutani H, Yamamura T, Nakanishi K: Persistent secretion of IL-18 in the skin contributes to IgE response in mice. Int Immunol 2003;15:611-621.
11. Sohn MH, Lee KE, Kim KE: Interleukin-18 is associated with increased severity of atopic dermatitis in children. Allergy Asthma Proc 2004;25:181-184.
12. Konishi H, Tsutsui H, Murakami T, Yumikura-Futatsugi S, Yamanaka K, Tanaka M, Iwakura Y, Suzuki N, Takeda K, Akira S, Nakanishi K, Mizutani H: IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci USA 2002;99:11340-11345.
13. Terada M, Tsutsui H, Imai Y, Yasuda K, Mizutani H, Yamanishi K, Kubo M, Matsui K, Sano H, Nakanishi K: Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice. Proc Natl Acad Sci USA 2006;103:8816-8821.
14. Terui T, Hirao T, Sato Y, Uesugi T, Honda M, Iguchi M, Matsumura N, Kudoh K, Aiba S, Tagami H: An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases. Exp Dermatol 1998;7:327-334.
15. Perkins MA, Cardin CW, Osterhues MA, Robinson MK: A non-invasive tape absorption method for recovery of inflammatory mediators to differentiate normal from compromised scalp conditions. Skin Res Technol 2002;8:187-193.
16. Forsgren A: Significance of protein A production by staphylococci. Infect Immun 1970;2:672-673.
17. Elias PM: Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005;125:183-200.
18. Novak N, Bieber T: Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003;112:252-262.
19. Flacher V, Bouschbacher M, Verronese E, Massacrier C, Sisirak V, Berthier-Vergnes O, de Saint-Vis B, Caux C, Dezutter-Dambuyant C, Lebecque S, Valladeau J: Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. Immunol 2006;177:7959-7967.
20. Mempel M, Voelcker V, Kollisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D, Ollert M: Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 2003;121:1389-1396.
21. Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, Kapsenberg ML, de Jong EC: Human keratinocytes express functional toll-like receptor 3, 4, 5, and 9. J Invest Dermatol 2007;127:331-341.
22. Gerold G, Zychlinsky A, de Diego JL: What is the role of toll-like receptors in bacterial infections? Semin Immunol 2007;19:41-47.
23. Bellou A, Schaub B, Ting L, Finn PW: Toll receptors modulate allergic responses: interaction with dendritic cells, T cells and mast cells. Curr Opin Allergy Clin Immunol 2003;3:487-494.
24. Miraglia del Giudice M, Decimo F, Leonardi S, Maioello N, Amelio R, Capasso A, Capristo C, Capristo AF: Immune dysregulation in atopic dermatitis. Allergy Asthma Proc 2006;27:451-455.
25. Akdis M, Akdis CA, Weigl L, Disch R, Blaser K: Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. J Immunol 1997;159:4611-4619.
26. Biedermann T: Dissecting the role of infections in atopic dermatitis. Acta Derm Venereol 2006;86:99-109.
27. Sibbald MJ, Ziebandt AK, Engelmann S, Hecker M, de Jong A, Harmsen HJ, Raangs GC, Stokroos I, Arends JP, Dubois JY, van Dijl JM: Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiol Mol Biol Rev 2006;70:755-788.
28. Tomi NS, Kranke B, Aberer E: Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J Am Acad Dermatol 2005;53:67-72.
29. Watson AR, Lee WT: Defective T cell receptor-mediated signal transduction in memory CD4 T lymphocytes exposed to superantigen or anti-T cell receptor antibodies. Cell Immunol 2006;242:80-90.
30. Kumar A, Tassopoulos AM, Li Q, Yu FS: Staphylococcus aureus protein A induced inflammatory response in human corneal epithelial cells. Biochem Biophys Res Commun 2007;354:55-61.
31. Hudson TJ: Skin barrier function and allergic risk. Nat Genet 2006;38:399-400.
32. Morar N, Willis-Owen SA, Moffatt MF, Cookson WO: The genetics of atopic dermatitis. J Allergy Clin Immunol 2006;118:24-34.
33. Huang SH: Gold nanoparticle-based immunochromatographic test for identification of Staphylococcus aureus from clinical specimens. Clin Chim Acta 2006;373:139-143.
34. De Jongh CM, Verberk MM, Withagen CE, Jacobs JJ, Rustemeyer T, Kezic S: Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis 2006;54:325-333.
35. Novak N, Kruse S, Potreck J, Maintz L, Jenneck C, Weidinger S, Fimmers R, Bieber T: Single nucleotide polymorphisms of the IL18 gene are associated with atopic eczema. J Allergy Clin Immunol 2005;115:828-833.
36. Raymond AA, Mechin MC, Nachat R, Toulza E, Tazi-Ahnini R, Serre G, Simon M: Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br J Dermatol 2007;156:20-27.
37. Iwatsuki K, Yamasaki O, Morizane S, Oono T: Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci 2006;42:203-214.